Literature DB >> 3626429

Thymoma presenting as a superior vena cava syndrome remission following therapy.

R Or, I Raz, D Raveh, G Lichovitzki, Y Kleinman.   

Abstract

A 45-year-old male developed myasthenia gravis 8 years ago. He received prednisone for 3 years, and resumed complete clinical remission. Five years later, he was admitted with obstruction of the superior vena cava. Invasive thymoma was diagnosed by chest X-ray and an open lung biopsy. Radiation followed by combination chemotherapy with cyclophosphamide, vincristine, and prednisone induced a complete remission. The patient remained disease-free for more than 20 months after the first admission to our department. To the best of our knowledge, superior vena cava syndrome as the presenting symptom of thymoma has never been reported previously.

Entities:  

Mesh:

Year:  1987        PMID: 3626429     DOI: 10.1007/BF01726671

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


  9 in total

1.  Sudden death caused by pressure of a thymoma on the right atrium.

Authors:  A ATSMON; J PINKHAS; M DJALDETTI
Journal:  Arch Intern Med       Date:  1962-09

2.  Management of superior vena cava syndrome.

Authors:  C A Perez; C A Presant; A L Van Amburg
Journal:  Semin Oncol       Date:  1978-06       Impact factor: 4.929

3.  Massive hemoptysis in a young man with myasthenia gravis and thymoma.

Authors: 
Journal:  Am J Med       Date:  1982-12       Impact factor: 4.965

4.  Myasthenia gravis and invasive thymoma: a 20-year experience.

Authors:  A J Goldman; C Herrmann; J C Keesey; D G Mulder; W J Brown
Journal:  Neurology       Date:  1975-11       Impact factor: 9.910

5.  Thymoma: a clinical and pathological study of 65 cases.

Authors:  W R Salyer; J C Eggleston
Journal:  Cancer       Date:  1976-01       Impact factor: 6.860

6.  Functional activities of autoantibodies to acetylcholine receptors and the clinical severity of myasthenia gravis.

Authors:  D B Drachman; R N Adams; L F Josifek; S G Self
Journal:  N Engl J Med       Date:  1982-09-23       Impact factor: 91.245

7.  Metastatic thymoma with myasthenia gravis: complete remission with combination chemotherapy.

Authors:  W M Butler; L F Diehl; H G Taylor; M D Weltz
Journal:  Cancer       Date:  1982-08-01       Impact factor: 6.860

8.  Chemotherapy of invasive thymoma.

Authors:  B Boston
Journal:  Cancer       Date:  1976-07       Impact factor: 6.860

9.  Combination chemotherapy in invasive thymoma role of COPP.

Authors:  W K Evans; D M Thompson; W J Simpson; R Feld; M J Phillips
Journal:  Cancer       Date:  1980-10-01       Impact factor: 6.860

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.